Assessment of lung-cancer mortality reduction from CT Screening
Authors:
- Paolo BoffettaPBPaolo Boffetta
- Olga GorlovaOGOlga Gorlova
- Rowena YipRYRowena Yip
- John O. DeLanceyJDJohn O. DeLancey
- Millennia FoyMFMillennia Foy
- 1 March 2011
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 71 (3) , 328-332
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screeningLung Cancer, 2007
- Survival of Patients with Stage I Lung Cancer Detected on CT ScreeningNew England Journal of Medicine, 2006
- Analysis of Mortality Data From Cancer Screening StudiesEpidemiology, 2005
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999
- Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Issues in the mortality analysis of randomized controlled trials of cancer screeningControlled Clinical Trials, 1994
- UICC workshop on the evaluation of screening programmes for cancer: Meeting held in Venice, Italy, on November 14‐16, 1983International Journal of Cancer, 1984
- Simple exact analysis of the standardised mortality ratio.Journal of Epidemiology and Community Health, 1984
- The Effects of Early Treatment, Lead Time and Length Bias on the Mortality Experienced by Cases Detected by ScreeningInternational Journal of Epidemiology, 1982
- Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers.Journal of Epidemiology and Community Health, 1978